Lactobacillus Acidophilus Capsules Recalled for Potential Labeling Mixup
Aidapak Services, LLC is recalling Lactobacillus Acidophilus capsules due to a potential labeling mixup with other medications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves minor labeling errors or low-risk contamination where the probability of temporary or medically reversible health consequences is remote.
Plain-English summary
Aidapak Services, LLC is recalling 2,392 capsules of Lactobacillus Acidophilus, an over-the-counter product. The recall is due to a labeling mixup where the product may be potentially mislabeled as Cholecalciferol, Tablet, 2000 units, or Pancrelipase DR, Capsule, 24000/76000/120000 USP units.
The affected product is identified by NDC 54629011101. The recall involves two specific pedigree codes: AD65311_7 and AD65311_4, both with an expiration date of 5/24/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication.
The recalled product
- Product
- LACTOBACILLUS ACIDOPHILUS Capsule, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 54629011101
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-the-Counter
- Hazard
- Affected units
- 2,392
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- LACTOBACILLUS ACIDOPHILUS
- Capsule has the following codes Pedigree: AD65311_7
- EXP: 5/24/2014
- Pedigree: AD65311_4
- EXP: 5/24/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateLactobacillus Acidophilus Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Cholecalciferol Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Cholecalciferol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- HighAidapak Recalls Acyclovir Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateFDA Recalls Calcium Polycarbophil Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Pancrelipase DR Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29